HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment.

Abstract
Diabetic wounds are imbued with an early excessive and protracted reactive oxygen species production. Despite the studies supporting PPARβ/δ as a valuable pharmacologic wound-healing target, the therapeutic potential of PPARβ/δ agonist GW501516 (GW) as a wound healing drug was never investigated. Using topical application of polymer-encapsulated GW, we revealed that different drug release profiles can significantly influence the therapeutic efficacy of GW and consequently diabetic wound closure. We showed that double-layer encapsulated GW microparticles (PLLA:PLGA:GW) provided an earlier and sustained dose of GW to the wound and reduced the oxidative wound microenvironment to accelerate healing, in contrast to single-layered PLLA:GW microparticles. The underlying mechanism involved an early GW-mediated activation of PPARβ/δ that stimulated GPx1 and catalase expression in fibroblasts. GPx1 and catalase scavenged excessive H2O2 accumulation in diabetic wound beds, prevented H2O2-induced ECM modification and facilitated keratinocyte migration. The microparticles with early and sustained rate of GW release had better therapeutic wound healing activity. The present study underscores the importance of drug release kinetics on the therapeutic efficacy of the drug and warrants investigations to better appreciate the full potential of controlled drug release.
AuthorsXiaoling Wang, Ming Keat Sng, Selin Foo, Han Chung Chong, Wei Li Lee, Mark Boon Yang Tang, Kee Woei Ng, Baiwen Luo, Cleo Choong, Marcus Thien Chong Wong, Benny Meng Kiat Tong, Shunsuke Chiba, Say Chye Joachim Loo, Pengcheng Zhu, Nguan Soon Tan
JournalJournal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 197 Pg. 138-47 (Jan 10 2015) ISSN: 1873-4995 [Electronic] Netherlands
PMID25449811 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • Delayed-Action Preparations
  • GW 501516
  • PPAR delta
  • PPAR-beta
  • Polyesters
  • Polymers
  • Reactive Oxygen Species
  • Thiazoles
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • poly(lactide)
  • Collagen
  • Hydrogen Peroxide
  • Catalase
  • Glutathione Peroxidase
Topics
  • Animals
  • Catalase (metabolism)
  • Cells, Cultured
  • Collagen (metabolism)
  • Delayed-Action Preparations
  • Diabetes Mellitus (drug therapy, metabolism)
  • Drug Delivery Systems
  • Fibroblasts (drug effects, metabolism)
  • Glutathione Peroxidase (metabolism)
  • HEK293 Cells
  • Humans
  • Hydrogen Peroxide (metabolism)
  • Lactic Acid (chemistry)
  • Male
  • Mice
  • Microscopy, Electron, Scanning
  • Oxidation-Reduction
  • PPAR delta (agonists)
  • PPAR-beta (agonists)
  • Polyesters
  • Polyglycolic Acid (chemistry)
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polymers (chemistry)
  • Reactive Oxygen Species (metabolism)
  • Thiazoles (administration & dosage, chemistry, pharmacology, therapeutic use)
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: